PlaqueTec Ltd. logo — Opening a new frontier in the fight against atherosclerosis

PlaqueTec Ltd.

Opening a new frontier in the fight against atherosclerosis

Founded 2008 United Kingdom Cambridge, United Kingdom 5 employees Series Unknown Total: $6.40M Health Care

General Information

Company Name PlaqueTec Ltd.
Founded Year 2008
Location United Kingdom Cambridge, United Kingdom +1
Employees 5
Industries Health Care
Funding Stage Series Unknown
Social

Get notified when PlaqueTec Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PlaqueTec Ltd.

PlaqueTec Ltd. is revolutionizing the fight against atherosclerosis with their novel approach to understanding coronary artery disease (CAD). Their slogan, "Opening a new frontier in the fight against atherosclerosis," encapsulates their mission. CAD, a leading global cause of death, has been limited by one-size-fits-all treatments. However, PlaqueTec aims to change this narrative with their proprietary technology and data analysis platform. Founded in 2008 and based in the United Kingdom, the company recently secured a significant £6.40M in a Venture Round investment on 30 April 2024. This investment was led by the Future Fund and Lord Moynihan. Their focus on developing precision medicine through a deeper understanding of patient endotypes holds the potential to revolutionize drug development and treatment efficacy. PlaqueTec's pursuit of uncovering potential biomarkers of coronary vascular function and plaque progression signifies a promising shift towards tailored treatments. This approach not only has the potential to reduce clinical trial sizes and costs but also increase success rates, ultimately improving patient outcomes. In the Health Care sector, PlaqueTec's innovative strides offer a glimpse into the future of personalized medicine and targeted interventions in the fight against CAD.

Taxonomy: Precision Medicine, Atherosclerosis, Coronary Artery Disease, Biomarker, Drug Development, Biopharmaceutical, Cardiology, Therapeutic Agents, Endotype, Clinical Trials, Inflammatory Processes, Plaque Progression, Vascular Function, Diagnostic Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £6.40M 2 Lord Moynihan 30 Apr 2024

PlaqueTec Ltd. Alternatives & Competitors

PlaqueTec Ltd. vs
Kaminari Medical
Kaminari Medical The Netherlands

Combining ultrasound and optical imaging to revolutionize coronary revascularization

Seed
7 employees
Health Care, Medical Devices
PlaqueTec Ltd. vs
Heartflow
Heartflow United States

Decisive Coronary Care.

IPO
823 employees
AI, Biotechnology
PlaqueTec Ltd. vs
SpectraWAVE, Inc.
SpectraWAVE, Inc. United States

Improving coronary artery disease outcomes with optical and computational insights.

Series B
56 employees
Biotechnology, Health Care

FAQ About PlaqueTec Ltd.

Opening a new frontier in the fight against atherosclerosis
PlaqueTec Ltd. was founded in 2008.
PlaqueTec Ltd. is headquartered in Cambridge, United Kingdom.
PlaqueTec Ltd. operates in the following industries: Health Care.
PlaqueTec Ltd. has approximately 5 employees.
PlaqueTec Ltd. has completed 1 funding round, raising a total of $6.40M. The latest funding stage is Series Unknown.
Top alternatives and competitors to PlaqueTec Ltd. include Kaminari Medical, Heartflow, SpectraWAVE, Inc., FluoroPharma Medical Inc., Morphic Therapeutic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PlaqueTec Ltd. and Kaminari Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PlaqueTec Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy